Medicine and Dentistry
Adolescent
38%
Antidiabetic Agent
7%
Beta Cell
5%
Body Mass Index
17%
C-Peptide
10%
Cardiovascular System
26%
Cell Function
33%
Diabetes
13%
Dysglycemia
33%
Epigenomics
5%
Gender Identity Disorder
26%
Glucose Tolerance
28%
Glycemic
7%
Glycemic Control
9%
Growth Hormone
26%
Hormone Therapy
26%
Human Growth Hormone
11%
Hypoglycemia
26%
Impaired Glucose Tolerance
8%
Insulin Dependent Diabetes Mellitus
53%
Insulin Release
29%
Insulin Resistance
30%
Insulin Response
10%
Insulin Sensitivity
15%
Insulin Sensitizing Agent
5%
Insulin Treatment
15%
Lipodystrophy
5%
Luteinizing Hormone
17%
Maturity Onset Diabetes of the Young
100%
Metabolic Syndrome
5%
Nonalcoholic Fatty Liver
5%
Obesity
37%
Oral Glucose Tolerance Test
33%
Pediatrics
7%
Pediatrics Patient
16%
Polycystic Ovary Syndrome
5%
Prevalence
32%
Retrospective Study
5%
Secretion (Process)
34%
Keyphrases
Adverse Health Consequences
5%
Basal LH
5%
Baseline Characteristics
26%
Body Mass Index
5%
Body Mass Index Percentile
5%
CD27
13%
CD28
26%
CD8+ T Cells
26%
Cell Dynamics
26%
Corticotrope
26%
Disease Duration
26%
Disposition Index
26%
Dysphoric
26%
Early-onset Type 2 Diabetes
26%
Female Patients
5%
Female Youth
5%
Female-to-male
21%
FSH Secretion
5%
Gender Dysphoria
26%
Hamster
26%
HbA1c Levels
5%
High Incidence
5%
High Prevalence
5%
Initial Manifestation
5%
Isolated GH Deficiency
26%
Juvenile Type
29%
Limited Information
5%
Multiorgan Effects
6%
Obesity-induced Insulin Resistance
6%
Ontogenesis
26%
Overweight or Obesity
5%
Pars Distalis
19%
Pediatric Endocrine
9%
Pediatric Patients
10%
Physiological Changes
26%
Physiological Growth
6%
Pituitary
26%
Potential Risk
5%
Prepubertal children
5%
Prolactin
26%
Pulse Amplitude
26%
Radioimmunoassay
26%
Retrospective Chart Review
5%
Sensitivity Relationships
15%
Syndrome Metabolic
6%
Type 1 Diabetes Mellitus (T1DM)
26%
Type I Diabetes
26%
Nursing and Health Professions
Adolescent
28%
Antidiabetic Agent
7%
Body Mass
17%
C Peptide
30%
Dysglycemia
53%
Female Patient
5%
Gender Dysphoria
26%
Glucose Blood Level
55%
Glucose Tolerance
52%
Gonadorelin
26%
Gonadotropin
26%
Gonadotropin Deficiency
5%
Growth Hormone Deficiency
26%
Hospital
5%
Hypoglycemia
26%
Insulin Treatment
12%
Linear Regression Analysis
26%
Non Insulin Dependent Diabetes Mellitus
91%
Obesity
37%
Oral Glucose Tolerance Test
57%
Pediatrics Patient
10%
Prevalence
5%